BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Explore effective strategies to maximize your credit card rewards. Get the most out of your spending and reap great benefits.
12,257 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Midweek is a prime time to refresh your investment plan. This Wednesday Reads guide breaks down tax-smart moves, mark...
Developed international value stocks are trading at discounts outside the U.S., and the Fidelity International Value ...
A bond ETF that regularly resets its income for inflation offers a unique hedge in today’s rate environment. Retirees...
AI-driven research is producing fake references at scale, threatening the reliability of published knowledge. The fal...
Institutional money flows into Bitcoin and Ethereum spur a new wave of adoption, while Solana, XRP, and Chainlink gro...
Speed isn’t everything in crypto, but it matters. This guide dives into why Avalanche is named among the avalanche fa...
This article breaks down the expected path for synopsys (snps) 2026 earnings, focusing on AI design driver demand, li...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
As crypto moves into the mainstream, investors wonder about Dogecoin's role. This guide outlines potential paths, ris...
Could Lilly ride a Nvidia-like surge? This piece analyzes whether the stock can follow Nvidia’s AI-driven momentum, f...